Shniakat, W.N. et al. 2023. Cytotoxic Evaluation of Doxorubicin Combination with Baicalein and Resveratrol Against Hct116 and Hepg2 Cancer Cell Lines (Conference Paper) #. Iraqi Journal of Pharmaceutical Sciences. 31, Suppl. (Feb. 2023), 92–99. DOI:https://doi.org/10.31351/vol31issSuppl.pp92-99.